Reproductive Outcome of Women with 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 41 of the 46 references it cites were found in a registry or an index.
Abstract
CONTEXT: Because many women with 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) carry at least one allele affected by a severe mutation of CYP21, they are at risk for giving birth to infants with classic adrenal hyperplasia (CAH). OBJECTIVE: Our objective was to determine the frequency of CAH and NCAH infants born to mothers with 21-OH-deficient NCAH. DESIGN AND SETTING: We conducted an international multicenter retrospective/prospective study. PATIENTS AND METHODS: The outcome of 203 pregnancies among 101 women with 21-OH-deficient NCAH was reviewed. The diagnosis of 21-OH-deficient NCAH was established by a basal or post-ACTH-stimulation 17-hydroxyprogesterone level of more than 10 ng/ml (30.3 nmol/liter). When possible, genotype analyses were performed to confirm CAH or NCAH in the offspring. RESULTS: Of the 203 pregnancies, 138 (68%) occurred before the mother's diagnosis of NCAH and 65 (32%) after the diagnosis. Spontaneous miscarriages occurred in 35 of 138 pregnancies (25.4%) before the maternal diagnosis of NCAH, and in only four of 65 pregnancies (6.2%) after the diagnosis (P < 0.002). Four (2.5%; 95% confidence interval, 0.7-6.2%) of the 162 live births were diagnosed with CAH. To date, 24 (14.8%; 95% confidence interval, 9.0-20.6%) children, 13 girls and 11 boys, have been diagnosed with NCAH. The distribution of NCAH children and their mothers varied significantly by ethnicity (P < 0.0001, for both). CONCLUSIONS: The risk of a mother with 21-OH-deficient NCAH for giving birth to a child affected with CAH is 2.5%; at least 14.8% of children born to these mothers have NCAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Both studies reported elevated miscarriage rates of ;25% in those not receiving GC and 6% in those exposed to GC.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, in two retrospective analyses of children born to women with NCCAH, the risk was higher, at 1.5% to 2.5% (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Second, optimizing mineralocorticoid treatment appears to improve fertility SW and SV patients (365,591,663), but the exact mechanism remains unknown.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [663]
Experimental — accuracy not yet measuredIn the citing paper
“GC treatment was given to induce fertility in 23% (234) and 42% (235) of cases.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
In the citing paper
“Two retrospective studies of pregnancies among women with NCCAH found that the majority of pregnancies occurred prior to the mother's diagnosis of NCCAH (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 1×
“The degree of hirsutism was assessed using a modified FerrimanGallwey scoring method, and hirsutism was considered to be present when a score of at least 8 was evident (23, 24).”
MethodCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Self-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationHirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Self-citation(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Research works printed but not linked: 1
- Prader, 1954, Der genitalbefund beim pseudohermaphroditismus femininus des kongenitalen androgenitalen syndroms, Helvetica Paediatr Acta, 3, 231
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Spontaneous abortions occurred more frequently before treatment in two such studies of referred reproductive endocrinology clinic patients (224,225).”
BackgroundSelf-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationAzziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationEscobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
“In addition, the prevalence of having a child with classic CAH is higher than predicted based on population frequency of mutation bearing CYP21A2 alleles (Moran et al., 2006).”
BackgroundSelf-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Self-citationCongenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
“Fertility and reproductive outcome in women with NCAH Despite the adrenal and ovarian androgen excess, the majority of women with NCAH will conceive spontaneously (Feldman et al., 1992; Moran et al., 2006) (Level of evidence: B).”
InfluentialSelf-citationCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Self-citationEscobar-Morreale, H. F., Sanchón, R., & San Millán, J. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2053 · Cited by 186
Self-citationNordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Prevalence of Polycystic Ovary Syndrome and Related Disorders in Mexican Women
Moran, C., Tena, G., Moran, S., Ruiz, P., Reyna, R., & Duque, X. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000277640 · Cited by 152
“For the purpose of this study, hypothyroidism was considered when TSH was higher than 5 μU/ml, hyperprolactinemia when PRL was higher than 25 ng/ml and nonclassic adrenal hyperplasia by basal or ACTH stimulated 17-HP levels higher than 10 ng/ml [”
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 159
Self-citationFalhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
“0 % stillborn infants at term appears to be similar to population data [49, 50].”
BackgroundApproach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121
“The diagnosis and treatment of nonclassic CAH has been reviewed in detail elsewhere (30, 31).”
BackgroundHealth Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
“However, this procedure bears also a number of risks, including surgical and anaesthetic complications and leaves the patient completely adrenal insufficient. Moreover, adrenal rest tissue may become hyperplastic and overproduce androgens postoperatively due to even increased ACTH drive after bilateral adrenalectomy.…”
BackgroundClinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
“High rates of miscarriages have, however, been demonstrated in untreated NC [155, 156], even rarely very late ones [158].”
BackgroundFertility in patients with congenital adrenal hyperplasia
Reichman, D. E., White, P. C., New, M. I., & Rosenwaks, Z. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.002 · Cited by 112
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
“Preliminarily, the preconception use of concomitant glucocorticoids appears to reduce the risk of miscarriages in NCAH patients conceiving [57].”
BackgroundInfluentialSelf-citationSteroid 21-hydroxylase deficiency in congenital adrenal hyperplasia
Parsa, A. A., & New, M. I. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.015 · Cited by 104
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Pignatelli, D., Carvalho, B. L., Palmeiro, A., Barros, A., Guerreiro, S. G., & Macut, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00432 · Cited by 95
“5% (71) and this increased risk was attributed to presumably higher carrier frequencies in certain ethnic groups.”
BackgroundSelf-citationRiepe, F. G., & Sippell, W. G. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9053-1 · Cited by 107
“About 50% of women with non-classical 21-OHD have difficulties to conceive without glucocorticoid therapy [124, 125].”
BackgroundPapadakis, G. E., Kandaraki, E., Tseniklidi, E., Papalou, O., & Diamanti‐Kandarakis, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00388 · Cited by 95
“5%, while the risk of non-classic deficiency is∼15% (59).”
BackgroundNandagopal, R., Sinaii, N., Avila, N. A., Van Ryzin, C., Chen, W., Finkielstain, G. P., Mehta, S. P., McDonnell, N. B., & Merke, D. P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0019 · Cited by 81
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
“An increased occurrence of miscarriages is typical of untreated NCCAH and may be the presenting symptom, but it is normalized by glucocorticoid treatment [11–14].”
BackgroundMANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
The next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Auchus, R., Witchel, S., Leight, K., Aisenberg, J., Azziz, R., Bachega, T., Baker, L., Baratz, A., Baskin, L., Berenbaum, S., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-275213 · Cited by 66
“5% risk of giving birth to a child with the classical form and a 15% risk of having a child with NCAH form [32].”
Self-citationHirschberg, A. L., Gidlöf, S., Falhammar, H., Frisén, L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa801 · Cited by 65
Management of CAH during pregnancy: optimizing outcomes
Witchel, S. F. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835a1a2e · Cited by 62
Self-citationNonclassic adrenal hyperplasia
Speiser, P. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9097-x · Cited by 68
“In one survey, 68% of 203 pregnancies occurred before the mother’s diagnosis of NCAH [ 23 ].”
BackgroundInfluentialSelf-citationFalhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01139 · Cited by 60
Livadas, S., & Bothou, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00366 · Cited by 57
“Hirsutism is the most common clinical manifestation reported in patients with NCCAH, ranging from 71 to 96% (28, 36).”
BackgroundInfluentialCongenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Hayashi, G. Y., Carvalho, D. F., de Miranda, M. C., Faure, C., Vallejos, C., Brito, V. N., Rodrigues, A. D. S., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13292 · Cited by 52
Self-citationNon-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Self-citationCosta‐Barbosa, F. A., Tonetto‐Fernandes, V. F., Carvalho, V. M., Nakamura, O. H., Moura, V., Bachega, T. A. S. S., Vieira, J. G. H., & Kater, C. E. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03871.x · Cited by 50
Self-citationNonclassic Congenital Adrenal Hyperplasia
Jha, S., & Turcu, A. F. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.008 · Cited by 64
Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome
Eyal, O., Ayalon‐Dangur, I., Segev‐Becker, A., Schachter‐Davidov, A., Israel, S., & Weintrob, N. (2017) · Clinical Endocrinology · doi:10.1111/cen.13429 · Cited by 47
Self-citationPignatelli, D. (2013) · Frontiers of Hormone Research · doi:10.1159/000342179 · Cited by 44
Self-citationNonclassic congenital adrenal hyperplasia
Witchel, S. F. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283534db2 · Cited by 42
“Among women with NCAH, spontaneous miscarriages occurred in 35/138 (25%) pregnancies preceding the mother’s diagnosis of NCAH and in 4/65 (6%) following diagnosis and treatment [40].”
BackgroundInfluentialSelf-citationNon-Classical Congenital Adrenal Hyperplasia in Childhood
Kurtoğlu, S., & Hatipoğlu, N. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3378 · Cited by 49
“NCCAH also increases the risk of classical and nonclassical CAH for the offspring babies of affected mothers (18).”
BackgroundChallenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum
Maher, J. Y., Gomez‐Lobo, V., & Merke, D. P. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09770-5 · Cited by 48
“Similar to polycystic ovary syndrome, which NCCAH is sometimes misdiagnosed as, the main cause of infertility is anovulation in 30–50% of patients [22, 41].”
BackgroundInfluentialReisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
“Fertility is only mildly reduced in non-classic CAH although two studies found that an increased miscarriage rate in non-classical CAH normalises with glucocorticoid treatment [64, 65].”
BackgroundPregnancy in Congenital Adrenal Hyperplasia
Reisch, N. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.011 · Cited by 36
The classic and nonclassic concenital adrenal hyperplasias
Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14474.ra · Cited by 35
Assisted Reproduction in Congenital Adrenal Hyperplasia
Chatziaggelou, A., Sakkas, E. G., Votino, R., Papagianni, M., & Mastorakos, G. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00723 · Cited by 39
Detection and management of late-onset 21-hydroxylase deficiency in women with hyperandrogenism
Young, J., Tardy, V., de la Perrière, A. B., Bachelot, A., & Morel, Y. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.009 · Cited by 35
Adult height of subjects with nonclassical 21-hydroxylase deficiency
Eyal, O., Tenenbaum‐Rakover, Y., Shalitin, S., Israel, S., & Weintrob, N. (2013) · Acta Paediatrica · doi:10.1111/apa.12147 · Cited by 33
“menstrual disturbances, hirsutism and fertility problems) (4, 18, 19).”
BackgroundSelf-citationFalhammar, H., Thoren, M., & Hagenfeldt, K. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345586 · Cited by 32
Disorders of Sexual Development in Adult Women
Gomez‐Lobo, V., Oelschlager, A. A., & for the North American Society for Pediatric and Adolescent Gynecology (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001672 · Cited by 34
“This is likely the result of intermarrying within ethnic subpopulations with higher carrier rates.(17)”
BackgroundFertility in patients with nonclassical congenital adrenal hyperplasia
New, M. I., Ghizzoni, L., Meyer‐Bahlburg, H. F. L., Khattab, A., Reichman, D. E., & Rosenwaks, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.023 · Cited by 27
Badeghiesh, A. M., Ismail, S., Baghlaf, H. A., Suarthana, E., & Dahan, M. H. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.08.036 · Cited by 25
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 24
Congenital adrenal hyperplasia
Demirci, C., & Witchel, S. F. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00216.x · Cited by 24
“The suggested explanation for the higher than expected prevalence was the tendency for affected individuals to marry within their own ethnic background; some ethnic groups are enriched for CYP21A2 variants (20).”
BackgroundSelf-citationMnif, M. F., Kamoun, M., Kacem, F. H., Mnif, F., Charfi, N., Naceur, B. B., Rekik, N., & Abid, M. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117196 · Cited by 22
“However, without glucocorticoid treatment, an increased miscarriage rate has been reported.[9-11]”
BackgroundRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Fertility and pregnancy outcomes in women with nonclassic 21‐hydroxylase deficiency
Carrière, C., Nguyen, L. S., Courtillot, C., Téjédor, I., Chakhtoura, Z., Bellanné‐Chantelot, C., Tardy, V., Leban, M., Touraine, P. A., & Bachelot, A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14842 · Cited by 25
Guo, X., Zhang, Y., Yu, Y., Zhang, L., Ullah, K., Ji, M., Jin, B., & Shu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.982953 · Cited by 23
[High frequency of thyroid abnormalities in polycystic ovary syndrome].
Calvar, C. E., Bengolea, S. V., Deutsch, S., Hermes, R., Ramos, G., & Loyato, M. (2015) · PubMed · Cited by 27
Maffazioli, G. D. N., Bachega, T. A. S. S., Hayashida, S. A. Y., Gomes, L. G., Valassi, H. P. L., Marcondes, J. A. M., Mendonca, B. B., Baracat, E. C., & Maciel, G. A. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa369 · Cited by 21
Self-citationCongenital Adrenal Hyperplasia
Chen, H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6430-3_48-2 · Cited by 19
Chesover, A., Millar, H., Sepiashvili, L., Adeli, K., Palmert, M. R., & Hamilton, J. K. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz030 · Cited by 15
“An individual with NCCAH has an increased chance of having offspring with NCCAH or classic CAH [3]; genetic counselling can support family planning.”
Evaluation and management of amenorrhea related to congenital sex hormonal disorders
Yoon, J. Y., & Cheon, C. K. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.149 · Cited by 17
Karachaliou, F.-E., Kafetzi, M. L., Dracopoulou, M., Vlachopapadopoulou, E. A., Leka, S., Fotinou, A., & Michalacos, S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0216 · Cited by 14
Pinkas, H., Fuchs, S., Aurbach-Klipper, Y., Zvulunov, A., Raanani, H., Sheffer-Mimouni, G., Fisch, B., & Weintrob, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.037 · Cited by 15
Self-citationLoli, P., Menotti, S., di Filippo, L., & Giustina, A. (2025) · Endocrine · doi:10.1007/s12020-025-04341-5 · Cited by 16
Zacharieva, S., Robeva, R. N., Andonova, S., Vazharova, R., Balabanski, L., Atanasoska, M., Toncheva, D. I., Elenkova, A. P., & Savov, A. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1482870 · Cited by 12
Dörr, H. G., Heß, J., Penger, T., Marx, M., & Oppelt, P. G. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2091-8 · Cited by 13
Approach to the Patient: Hirsutism
Azziz, R., Amiri, M., Bril, F., Joham, A. E., Keleştimur, F., Ottey, S., Сутурина, Л. В., Tay, C. T., Teede, H. J., Yıldız, B. O., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf226 · Cited by 22
Self-citationGüneş, S. O., Kendırcı, H. N. P., Ünal, E., Buluş, A. D., Dündar, İ., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-6-s · Cited by 18
“In two studies in which children born to women with NCCAH were retrospectively analyzed, the risk of having a child with classical 21-OHD was found to be 1.5-2.5% (46,47).”
InfluentialLu, F.-F., Wang, Z., Yang, Q., Yan, F.-S., Xu, C., Wang, M.-T., Xu, Z.-J., Cai, S.-Y., & Guan, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1438079 · Cited by 11
Chernykh, E. R., Leplina, O. Y., Tikhonova, M. A., Селедцова, Н. В., Викторовна, Т. Т., Khonina, N. A., Ostanin, A. A., & Pasman, N. M. (2015) · BMC Immunology · doi:10.1186/s12865-014-0065-9 · Cited by 9
“Because similar immune abnormalities have been described in women with recurrent miscarriages [30,31], we suggested that immune dysfunction might be the cause of the increased abortion rate in pregnant women with elevated levels of DHEAS [32,33].”
BackgroundPasqualini, T., Alonso, G., Tomasini, R., Galich, A. M., Buzzalino, N. D., Fernández, C. S., Minutolo, C., Alba, L. G., & Daín, L. (2007) · PubMed · Cited by 12
Robin, G., Decanter, C., Baffet, H., Catteau-Jonard, S., & Dewailly, D. (2014) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2014.04.005 · Cited by 8
“déjà été rapporté dans la littérature [12,17,18].”
BackgroundSelf-citationClassic virilizing congenital adrenal hyperplasia presenting late: case series from Pakistan.
Khan, A. H., Aban, M., Rameez-ul-Hassan, Naeem-ul-Haq, Raza, J., Jabbar, A., & Moatter, T. (2009) · PubMed · Cited by 8
Reproductive Outcome of Women with 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia
Rogol, A. D. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70251-8 · Cited by 8
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 13
“Spontaneous abortion rates across all phenotypes range from 6.5% to 26.3% [34, 35, 51, 52].”
InfluentialThe impact of genetic steroid disorders on human fertility
Reichman, D., & Rosenwaks, Z. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.014 · Cited by 9
Segev‐Becker, A., Jacobson, R., Stein, R., Eyal, O., Oren, A., Schachter‐Davidov, A., Israeli, G., Lebenthal, Y., & Weintrob, N. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0509 · Cited by 10
Self-citationPurwana, I. N., Kanasaki, H., Oride, A., & Miyazaki, K. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.01903.x · Cited by 8
“Subfertility is relative in NCCAH,(7,8) although there was a higher incidence of spontaneous miscarriage.(9) NCCAH women with menstrual dysfunction”
BackgroundClinical Concerns on Sex Steroids Variability in Cisgender and Transgender Women Athletes
Luigi, L. D., Greco, E. A., FOSSATI, C., Aversa, A., Sgrò, P., & Antinozzi, C. (2022) · International Journal of Sports Medicine · doi:10.1055/a-1909-1196 · Cited by 9
Fertility and pregnancy in adrenal insufficiency
Green, D., Dineen, R., O’Reilly, M., & Sherlock, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0088 · Cited by 13
“There is an increased risk of miscarriage in women with non-classic CAH, which is reduced with glucocorticoid therapy ( 86 , 87 , 88 ).”
BackgroundJiang, S., & Kuang, Y. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0893-3122 · Cited by 7
“4 % [12], both significantly higher than our data.”
BackgroundResultInfluentialGenetic characterization of a large cohort of Argentine 21‐hydroxylase Deficiency
Fernández, C. S., Taboas, M., Bruque, C. D., Benavides‐Mori, B., Belli, S., Stivel, M., Oneto, A., Pasqualini, T., Delea, M., Espeche, L. D., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14190 · Cited by 7
Reproductive Function and Fertility in Women with Congenital Adrenal Hyperplasia
Pereira, N., & Lin‐Su, K. (2018) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/10314092 · Cited by 6
Adrenal hyperplasias in childhood: An update
Pitsava, G., & Stratakis, C. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.937793 · Cited by 6
Zamila, B. M., Banu, H., Morshed, M. S., Shah, S., Begum, A., Sultana, T., Akhtar, N., Fariduddin, M., Saleh, A. A., & Hasanat, M. (2022) · International Journal of Human and Health Sciences (IJHHS) · doi:10.31344/ijhhs.v6i1.383 · Cited by 5
Эдуардовна, Г. Е., & Kurtser, M. A. (2017) · Human Fertility · doi:10.1080/14647273.2017.1344360 · Cited by 6
“A timely diagnosis and treatment of NCAH may help reduce risk of pregnancy loss and overcome infertility (Bidet et al., 2010; Feldman et al., 1992; Moran et al., 2006).”
BackgroundVieira, A., Paiva, S., Baptista, C. F., Ruas, L., Silva, J., Gonçalves, J., Carrilho, F., & Carvalheiro, M. C. (2011) · Acta Médica Portuguesa · doi:10.20344/amp.338 · Cited by 6
Pregnancy in Congenital Adrenal Hyperplasia
Reisch, N., & Auchus, R. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.005 · Cited by 7
Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency
Liu, E., Luo, H., Zhou, K., & Zhang, Y. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-06946-5 · Cited by 5
“Infertility continues to be the leading cause of hospital visits for most patients with NC21OHD, although some data suggest that some patients with NC21OHD have only mildly impaired fertility, not necessarily infertility [13, 20, 31].”
BackgroundResultInfluential
Metadata
- Authors
- Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., Mendonca, B. B., Bachega, T. A. S., Escobar-Morreale, H. F., Carmina, E., Fruzzetti, F., & Kelestimur, F.
- Affiliations
- Mexican Institute of Social Security (C.M.), 06725 Mexico City, Mexico
- Cedars-Sinai Medical Center (US)
- Schneider Children's Medical Center (IL)
- Children's Hospital of Pittsburgh (US)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Hospices Civils de Lyon (FR)
- Schneider Children's Hospital (US)
- Universidade do Porto (PT)
- Hospital Universitario Ramón y Cajal (ES)
- University of Palermo (IT)
- University of Pisa (IT)
- Erciyes University Medical School (F.K.), 3805 Kayseri, Turkey
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 91
- Issue
- 9
- Pages
- 3451-3456
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001112976
- Cited by
- 174
- References
- 46
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 9
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- U.S. Public Health Service (K24-D01346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, CYP21, pregnancy outcomes, miscarriage, prenatal diagnosis, ethnic differences, genotype analysis, 17-hydroxyprogesterone
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Child, Preschool, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Pregnancy, Prospective Studies, Retrospective Studies, Steroid 21-Hydroxylase, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.